KERYX BIOPHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
13 Sep 2017	Form 3: Enyedy Mark J, Director No securities owned
18 Jan 2017	Form 3: Carberry Christine A., Chief Operating Officer No securities owned
23 Jun 2016	Form 3: Heffernan Michael Thomas, Director No securities owned
23 Jun 2016	Form 3: Morrison Jodie Pope, Director No securities owned
08 Apr 2016	Form 3: Rogers Michael W, Director
08 Apr 2016	Form 3: Gilman Steven C, Director
10 Dec 2015	Form 3: Butler John P., Director Holds 10,000 shares of Common Stock (Restricted)
20 Oct 2015	Form 3: Baupost Group LLC/MA, 10% owner and 2 others Holds 42,016,276 shares of Common Stock
03 Aug 2015	Form 3: Holmes Scott A, Chief Financial Officer Holds 7,500 shares of Common Stock (Restricted)
30 Apr 2015	Form 3: Neylan John F., Chief Medical Officer Holds 45,000 shares of Common Stock (Restricted)
17 Mar 2015	Form 3: Adams Brian, General Counsel Holds 40,000 shares of Common Stock (Restricted)
13 Feb 2014	Form 3: Madison Greg, See Remarks Holds 76,547 shares of Common Stock
07 Oct 2013	Form 3: Regan Daniel Paul, Director Holds 10,000 shares of Common Stock (Restricted)
27 Jul 2010	Form 3: Feczko Joseph M, Director
22 May 2009	Form 3: Bentsur Ron, CEO Holds 206,661 shares of COMMON STOCK
16 May 2008	Form 3: Oliviero James F Iii, Vice President of Finance
26 Sep 2007	Form 3: Tarnok Michael P., Director
04 May 2007	Form 3: Cameron Kevin J, Director
30 Apr 2007	Form 3: Levine Beth F, General Counsel, SVP, CCO, SEC Holds 15,000 shares of Common Stock
30 Mar 2007	Form 3: Stier Mark, Chief Accounting Officer, VP

Comments